SK Bioscience joins $99m BDBV vaccine development project
SK Bioscience said Thursday it will join a Bundibugyo virus vaccine development project backed by up to $99 million from the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority. The initiative, involving nonprofit research organizations IAVI and Hi

SK Bioscience said Thursday it will join a Bundibugyo virus vaccine development project backed by up to $99 million from the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority. The initiative, involving nonprofit research organizations IAVI and Hi
💬 留言板 — 歡迎分享你的想法!
登入 Google 帳號即可留言